Stay updated on Daratumumab in PGNMID and C3 GN Clinical Trial
Sign up to get notified when there's something new on the Daratumumab in PGNMID and C3 GN Clinical Trial page.

Latest updates to the Daratumumab in PGNMID and C3 GN Clinical Trial page
- Check2 days agoNo Change Detected
- Check9 days agoNo Change Detected
- Check16 days agoChange DetectedThe page now shows Revision: v3.5.0 and no longer displays Revision: v3.4.3.SummaryDifference0.1%

- Check23 days agoNo Change Detected
- Check30 days agoChange DetectedPage revision updated from v3.4.2 to v3.4.3. This appears to be a minor page update.SummaryDifference0.1%

- Check52 days agoChange Detected- Updated page revision tag from v3.4.1 to v3.4.2; no impact on study content or user workflow.SummaryDifference0.1%

- Check59 days agoChange DetectedAn administrative version update is shown: 'Revision: v3.4.1' was added and 'Revision: v3.4.0' was removed. This appears to be metadata about the site and does not alter study data or page content.SummaryDifference0.1%

- Check74 days agoChange DetectedAdded UI elements and labels: Show glossary and Hide glossary, and updated metadata fields with 'Last Update Submitted that Met QC Criteria' and 'No FEAR Act Data', plus Revision: v3.4.0. Removed or replaced older labels: 'Last Update Submitted that met QC Criteria', 'No FEAR Act data', and Revision: v3.3.4.SummaryDifference0.4%

- Check81 days agoChange DetectedThe page now shows Revision: v3.3.4, replacing Revision: v3.3.3. No substantive content or layout changes are evident.SummaryDifference0.1%

Stay in the know with updates to Daratumumab in PGNMID and C3 GN Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Daratumumab in PGNMID and C3 GN Clinical Trial page.